Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP921682.RAardhGSxCUhPzRfWZfI1SuKbDI12WoX6-hghCIPGjpew130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP921682.RAardhGSxCUhPzRfWZfI1SuKbDI12WoX6-hghCIPGjpew130_assertion type Assertion NP921682.RAardhGSxCUhPzRfWZfI1SuKbDI12WoX6-hghCIPGjpew130_head.
- NP921682.RAardhGSxCUhPzRfWZfI1SuKbDI12WoX6-hghCIPGjpew130_assertion description "[The most relevant new agent in gastric cancer therapy is trastuzumab for HER2-positive gastric carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP921682.RAardhGSxCUhPzRfWZfI1SuKbDI12WoX6-hghCIPGjpew130_provenance.
- NP921682.RAardhGSxCUhPzRfWZfI1SuKbDI12WoX6-hghCIPGjpew130_assertion evidence source_evidence_literature NP921682.RAardhGSxCUhPzRfWZfI1SuKbDI12WoX6-hghCIPGjpew130_provenance.
- NP921682.RAardhGSxCUhPzRfWZfI1SuKbDI12WoX6-hghCIPGjpew130_assertion SIO_000772 21896085 NP921682.RAardhGSxCUhPzRfWZfI1SuKbDI12WoX6-hghCIPGjpew130_provenance.
- NP921682.RAardhGSxCUhPzRfWZfI1SuKbDI12WoX6-hghCIPGjpew130_assertion wasDerivedFrom befree-2016 NP921682.RAardhGSxCUhPzRfWZfI1SuKbDI12WoX6-hghCIPGjpew130_provenance.
- NP921682.RAardhGSxCUhPzRfWZfI1SuKbDI12WoX6-hghCIPGjpew130_assertion wasGeneratedBy ECO_0000203 NP921682.RAardhGSxCUhPzRfWZfI1SuKbDI12WoX6-hghCIPGjpew130_provenance.